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Background
Chronic conditions such as asthma are usually stigma-
tized as one of the reasons for short stature. A wide-
spread belief also is that prolonged long-term treatment
with corticosteroids will lead to elevated body weight
and also could lead to short stature.
Therefore we evaluated the height and weight status
in the children admitted in the hospital for asthma
attack regarding the asthma severity, the natural history
of asthma and inhaled corticosteroid (ICS) treatment
period.
Material and method
For a period of 6 months (Jan- Jun 2014) we evaluated
100 (54 boys, mean age 7,48±0.53 and 46 girls, mean
age 7.66±0.64) children admitted for asthma attack. A
detailed natural history, disease summary, pulmonary
function test, bronchodilation test and anthropometric
data were gathered, as well as data for a control group
of 132 patients with acute respiratory infections
matched by age and sex.
Results
49 asthmatic patients have been using ICS (18 for more
than 5 years). There were not any significant correla-
tions between height, weight, BMI (SDS) and the ICS
treatment period, the time without controller therapy,
BDR response, birth weight, the asthma duration, family
history or atopy status (p>0,05, r 0,01-0,2). No differ-
ences were found in height SDS when the kids were
stratified according ICS treatment and its duration (less
or over 5 years)(p>0,1), the same results came for weight
(p>0,1) and BMI (p>0,1). Comparing with the control
group, there is not a significant difference in weight
(p=0,07 asthma vs controls, p=0,15 asthma on ICS vs
controls), height (p=0.06 asthma on ICS vs. controls).
Severe asthma patients (11 on high dose combined cor-
ticosteroids ± montelucast) also don’t show any signifi-
cant difference in height, BMI and weight compared to
other asthma patients (p>0,5). Long-term not treated
asthmatics also don’t have any significant difference in
anthropometric data compared to other asthmatics.
Conclusion
Long-term ICS therapy or not proper treatment is not that
determining for height and weight status in asthma
patients. Interesting future study would determine
whether there is a correlation between different food beha-
vior and exercise pattern that could lead the previously
published data.
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